Statement of Retraction: Omega-3 fatty acid supplementation affects pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebo-controlled trial (The Journal of Maternal-Fetal & Neonatal Medicine, (2016), 29, 4, (669-675), 10.3109/14767058.2015.1015980);Omega-3 fatty acid supplementation affects pregnancy outcomes in gestational diabetes: A randomized, double-blind, placebo-controlled trial

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 29, Issue 4, 2016, Pages 669-675

  Jamilian, Mehri ^a   Samimi, Mansooreh ^b   Kolahdooz, Fariba ^c   Khalaji, Farzaneh ^b   Razavi, Maryamalsadat ^d   Asemi, Zatollah ^b  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF ALBERTA   (Canada)

^d ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gestational diabetes; omega 3 fatty acid; pregnancy outcomes; pregnant women; supplementation

Indexed keywords

C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; MALONALDEHYDE; OMEGA 3 FATTY ACID;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CALORIC INTAKE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FAT INTAKE; FEMALE; HEAD CIRCUMFERENCE; HUMAN; HYPERBILIRUBINEMIA; INCIDENCE; MAJOR CLINICAL STUDY; NEONATAL HYPERBILIRUBINEMIA; OXIDATIVE STRESS; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; BLOOD; DIABETES, GESTATIONAL; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; HOSPITALIZATION; HYPERBILIRUBINEMIA, NEONATAL; IRAN; NEWBORN; PREGNANCY; STATISTICS AND NUMERICAL DATA;

ADULT; C-REACTIVE PROTEIN; DIABETES, GESTATIONAL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; HOSPITALIZATION; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; IRAN; MALONDIALDEHYDE; PREGNANCY;

EID: 84950326808     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767058.2024.2364980     Document Type: Erratum

References (47)

1. Landon MB, Gabbe SG. Gestational diabetes mellitus. Obstet Gynecol 2011;118:1379-93.
2. Inkster ME, Fahey TP, Donnan PT, et al. Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnan Childbirth 2006;6:30.
3. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002.
4. Lopez-Tinoco C, Roca M, Fernandez-Deudero A, et al. Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine 2012;58:14-19.
5. Roca-Rodriguez MM, Lopez-Tinoco C, Murri M, et al. Postpartum development of endothelial dysfunction and oxidative stress markers in women with previous gestational diabetes mellitus. J Endocrinol Invest 2014;37:503-9.
6. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-23.
7. Oostdam N, van Poppel MN, Wouters MG, et al. Interventions for preventing gestational diabetes mellitus: A systematic review and meta-analysis. J Womens Health (Larchmt) 2011;20:1551-63.
8. Asemi Z, Karamali M, Esmaillzadeh A. Favorable effects of vitamin d supplementation on pregnancy outcomes in gestational diabetes: A double blind randomized controlled clinical trial. Horm Metab Res 2014. [Epub ahead of print].
9. Asemi Z, Samimi M, Tabassi Z, Esmaillzadeh A. The effect of DASH diet on pregnancy outcomes in gestational diabetes: A randomized controlled clinical trial. Eur J Clin Nutr 2014;68: 490-5.
10. Samimi M, Jamilian M, Asemi Z, et al. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial. Clin Nutr 2014. [Epub ahead of print]. doi: 10.1016/ j.clnu.2014.06.005.
11. Bitsanis D, Ghebremeskel K, Moodley T, et al. Gestational diabetes mellitus enhances arachidonic and docosahexaenoic acids in placental phospholipids. Lipids 2006;41:341-6.
12. Imhoff-Kunsch B, Briggs V, Goldenberg T, et al. Effect of n-3 longchain polyunsaturated fatty acid intake during pregnancy on maternal, infant, and child health outcomes: A systematic review. Paediatr Perinat Epidemiol 2012;26:91-107.
13. Carlson SE, Colombo J, Gajewski BJ, et al. DHA supplementation and pregnancy outcomes. Am J Clin Nutr 2013;97:808-15.
14. Rogers I, Emmett P, Ness A, et al. Maternal fish intake in late pregnancy and the frequency of low birth weight and intrauterine growth retardation in a cohort of British infants. J Epidemiol Community Health 2004;58:486-92.
15. Olsen SF, Secher NJ, Tabor A, et al. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG 2000;107:382-95.
16. Frew L, Sugiarto NU, Rajagopal SP, et al. The effect of omega-3 polyunsaturated fatty acids on the inflammatory response of the amnion. Prostaglandin Leukot Essent Fatty Acid 2013;89:221-5.
17. Li H, Ruan XZ, Powis SH, et al. EPA and DHA reduce LPSinduced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int 2005;67:867-74.
18. Fisher M, Levine PH, Weiner BH, et al. Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am J Clin Nutr 1990;51:804-8.
19. Takahashi M, Tsuboyama-Kasaoka N, Nakatani T, et al. Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production. Am J Physiol Gastrointest Liver Physiol 2002;282:G338-48.
20. Mori TA, Woodman RJ, Burke V, et al. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 2003;35:772-81.
21. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37:S81-90.
22. Nobile de Santis MS, Radaelli T, Taricco E, et al. Excess of amniotic fluid: pathophysiology, correlated diseases and clinical management. Acta Biomed 2004;75:53-5.
23. Porter ML, Dennis BL. Hyperbilirubinemia in the term newborn. Am Fam Physician 2002;65:599-606.
24. Tatsch E, Bochi GV, Pereira Rda S, et al. A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem 2011;44:348-50.
25. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay. Anal Biochem 1996;239:70-6.
26. Beutler E, Gelbart T. Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 1985;105:581-4.
27. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990;9:515-40.
28. Bener A, Saleh NM, Al-Hamaq A. Prevalence of gestational diabetes and associated maternal and neonatal complications in a fast-developing community: global comparisons. Int J Womens Health 2011;3:367-73.
29. Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 2003;102:857-68.
30. Jelsema RD. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 2004;103:586; author reply-7.
31. Linne Y, Barkeling B, Rossner S. Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study. BJOG 2002;109:1227-31.
32. Rallidis LS, Paschos G, Liakos GK, et al. Dietary alphalinolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003;167: 237-42.
33. Li K, Huang T, Zheng J, et al. Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor alpha: A meta-analysis. PLoS One 2014;9: e88103.
34. Iraz M, Erdogan H, Ozyurt B, et al. Brief communication: omega-3 essential fatty acid supplementation and erythrocyte oxidant/ antioxidant status in rats. Ann Clin Lab Sci 2005;35:169-73.
35. Chan DC, Watts GF, Barrett PH, et al. Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clin Chem 2002;48:877-83.
36. Rossi A, Kapahi P, Natoli G, et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 2000;403:103-8.
37. Robinson LE, Buchholz AC, Mazurak VC. Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome. Appl Physiol Nutr Metab 2007;32:1008-24.
38. Hassan Eftekhari M, Aliasghari F, Babaei-Beigi MA, et al. Effect of conjugated linoleic acid and omega-3 fatty acid supplementation on inflammatory and oxidative stress markers in atherosclerotic patients. ARYA Atheroscler 2013;9:311-18.
39. Tayyebi-Khosroshahi H, Houshyar J, Tabrizi A, et al. Effect of omega-3 fatty acid on oxidative stress in patients on hemodialysis. Iran J Kidney Dis 2010;4:322-6.
40. Accinni R, Rosina M, Bamonti F, et al. Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutr Metab Cardiovasc Dis 2006;16: 121-7.
41. Oarada M, Tsuzuki T, Gonoi T, et al. Effects of dietary fish oil on lipid peroxidation and serum triacylglycerol levels in psychologically stressed mice. Nutrition 2008;24:67-75.
42. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005;15:316-28.
43. Zulyniak MA, Perreault M, Gerling C, et al. Fish oil supplementation alters circulating eicosanoid concentrations in young healthy men. Metabolism 2013;62:1107-13.
44. Jakesevic M, Aaby K, Borge GI, et al. Antioxidative protection of dietary bilberry, chokeberry and Lactobacillus plantarum HEAL19 in mice subjected to intestinal oxidative stress by ischemiareperfusion. BMC Complement Altern Med 2011;11:8.
45. Heller AR, Rossel T, Gottschlich B, et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004;111:611-16.
46. D'Ascenzo R, Savini S, Biagetti C, et al. Higher Docosahexaenoic acid, lower Arachidonic acid and reduced lipid tolerance with high doses of a lipid emulsion containing 15% fish oil: A randomized clinical trial. Clin Nutr 2014;33:1002-9.
47. Zhou SJ, Yelland L, McPhee AJ, et al. Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. Am J Clin Nutr 2012;95:1378-84.